ArticleJCO precision oncology2024

Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary.

Harry E Fuentes Bayne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.